Julen Oyarzábal (Julen Oyarzabal)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2022
Publications (10 Years): 14

Top Venues

Journal of medicinal chemistry

ACS chemical neuroscience

Thrombosis and haemostasis

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Manuel Navarro-Oviedo, Juan Marta-Enguita, Carmen Roncal, Jose Antonio Rodríguez, Beatriz Zandio, Ramón Lecumberri, Jose Hermida, Julen Oyarzábal, Antonio Pineda-Lucena, Jose Antonio Paramo, Roberto Muñoz, Josune Orbe
CM-352 Efficacy in a Mouse Model of Anticoagulant-Associated Intracranial Hemorrhage. Thrombosis and haemostasis 122 (8) (2022)
Obdulia Rabal, Edurne San José-Enériz, Xabier Agirre, Juan Antonio Sánchez-Arias, Irene de Miguel, Raquel Ordoñez, Leire Garate, Estíbaliz Miranda, Elena Sáez, Amaia Vilas-Zornoza, Antonio Pineda-Lucena, Ander Estella, Feifei Zhang, Wei Wu, Musheng Xu, Felipe Prosper, Julen Oyarzábal
Design and Synthesis of Novel Epigenetic Inhibitors Targeting Histone Deacetylases, DNA Methyltransferase 1, and Lysine Methyltransferase G9a with In Vivo Efficacy in Multiple Myeloma. Journal of medicinal chemistry 64 (6) (2021)
Vicente Fresquet, Maria-Jose Garcia-Barchino, Marta Larrayoz, Jon Celay, Carmen Vicente, Marta Fernandez-Galilea, Maria J Calasanz, Carlos Panizo, Alexandra Junza, Jiahuai Han, Celia Prior, Puri Fortes, Ruben Pio, Julen Oyarzábal, Alvaro Martinez-Baztan, Bruno Paiva, María Jesús Moreno-Aliaga, Maria-Dolores Odero, Xabier Agirre, Oscar Yanes, Felipe Prosper, Jose A Martinez-Climent
Endogenous Retroelement Activation by Epigenetic Therapy Reverses the Warburg Effect and Elicits Mitochondrial-Mediated Cancer Cell Death. Cancer discovery 11 (5) (2020)
Sandra Codony, Eugènia Pujol, Javier Pizarro, Ferran Feixas, Elena Valverde, M Isabel Loza, José M Brea, Elena Saez, Julen Oyarzábal, Antonio Pineda-Lucena, Belén Pérez, Concepción Pérez, María Isabel Rodríguez-Franco, Rosana Leiva, Sílvia Osuna, Christophe Morisseau, Bruce D Hammock, Manuel Vázquez-Carrera, Santiago Vázquez
2-Oxaadamant-1-yl Ureas as Soluble Epoxide Hydrolase Inhibitors: In Vivo Evaluation in a Murine Model of Acute Pancreatitis. Journal of medicinal chemistry 63 (17) (2020)
Edgar López-López, Obdulia Rabal, Julen Oyarzábal, José Luis Medina-Franco
Towards the understanding of the activity of G9a inhibitors: an activity landscape and molecular modeling approach. Journal of computer-aided molecular design 34 (6) (2020)
Pedro Urquiza, Ana Laín, Arantza Sanz-Parra, Jorge Moreno, Ganeko Bernardo-Seisdedos, Pierre Dubus, Esperanza Gonzalez, Virginia Gutiérrez-de-Juan, Sandra García, Hasier Eraña, Itxaso San Juan, Iratxe Macías, Fredj Ben Bdira, Paula Pluta, Gabriel Ortega, Julen Oyarzábal, Rosario González-Muñiz, Juan Rodríguez-Cuesta, Juan Anguita, Emilio Díez, Jean-Marc Blouin, Hubert de Verneuil, José M Mato, Emmanuel Richard, Juan M Falcón-Pérez, Joaquín Castilla, Óscar Millet
Repurposing ciclopirox as a pharmacological chaperone in a model of congenital erythropoietic porphyria. Science translational medicine 10 (459) (2019)
Obdulia Rabal, Juan A Sánchez-Arias, Mar Cuadrado-Tejedor, Irene de Miguel, Marta Pérez-González, Carolina García-Barroso, Ana Ugarte, Ander Estella-Hermoso de Mendoza, Elena Sáez, Maria Espelosin, Susana Ursua, Haizhong Tan, Wei Wu, Musheng Xu, Antonio Pineda-Lucena, Ana Garcia-Osta, Julen Oyarzábal
Multitarget Approach for the Treatment of Alzheimer's Disease: Inhibition of Phosphodiesterase 9 (PDE9) and Histone Deacetylases (HDACs) Covering Diverse Selectivity Profiles. ACS chemical neuroscience 10 (9) (2019)
Patricia Letrado, Irene de Miguel, Iranzu Lamberto, Roberto Díez-Martínez, Julen Oyarzábal
Zebrafish: Speeding Up the Cancer Drug Discovery Process. Cancer research 78 (21) (2018)
Obdulia Rabal, Edurne San José-Enériz, Xabier Agirre, Juan Antonio Sánchez-Arias, Amaia Vilas-Zornoza, Ana Ugarte, Irene de Miguel, Estíbaliz Miranda, Leire Garate, Mario Fraga, Pablo Santamarina, Raul Fernandez Perez, Raquel Ordoñez, Elena Sáez, Sergio Roa, María José García-Barchino, José Angel Martínez-Climent, Yingying Liu, Wei Wu, Musheng Xu, Felipe Prosper, Julen Oyarzábal
Discovery of Reversible DNA Methyltransferase and Lysine Methyltransferase G9a Inhibitors with Antitumoral in Vivo Efficacy. Journal of medicinal chemistry 61 (15) (2018)
Obdulia Rabal, Juan A Sánchez-Arias, Mar Cuadrado-Tejedor, Irene de Miguel, Marta Pérez-González, Carolina García-Barroso, Ana Ugarte, Ander Estella-Hermoso de Mendoza, Elena Sáez, Maria Espelosin, Susana Ursua, Tan Haizhong, Wu Wei, Xu Musheng, Ana Garcia-Osta, Julen Oyarzábal
Discovery of in Vivo Chemical Probes for Treating Alzheimer's Disease: Dual Phosphodiesterase 5 (PDE5) and Class I Histone Deacetylase Selective Inhibitors. ACS chemical neuroscience 10 (3) (2018)
Obdulia Rabal, Juan Antonio Sánchez-Arias, Edurne San José-Enériz, Xabier Agirre, Irene de Miguel, Leire Garate, Estibaliz Miranda, Elena Sáez, Sergio Roa, José Angel Martínez-Climent, Yingying Liu, Wei Wu, Musheng Xu, Felipe Prosper, Julen Oyarzábal
Detailed Exploration around 4-Aminoquinolines Chemical Space to Navigate the Lysine Methyltransferase G9a and DNA Methyltransferase Biological Spaces. Journal of medicinal chemistry 61 (15) (2018)
Javier Vázquez, Alessandro Deplano, Albert Herrero, Tiziana Ginex, Enric Gibert, Obdulia Rabal, Julen Oyarzábal, Enric Herrero, Francisco Javier Luque
Development and Validation of Molecular Overlays Derived from Three-Dimensional Hydrophobic Similarity with PharmScreen. Journal of chemical information and modeling 58 (8) (2018)
Martin Krallinger, Obdulia Rabal, Anália Lourenço, Julen Oyarzábal, Alfonso Valencia
Information Retrieval and Text Mining Technologies for Chemistry. Chemical reviews 117 (12) (2017)
Juan A Sánchez-Arias, Obdulia Rabal, Mar Cuadrado-Tejedor, Irene de Miguel, Marta Pérez-González, Ana Ugarte, Elena Sáez, Maria Espelosin, Susana Ursua, Tan Haizhong, Wu Wei, Xu Musheng, Ana Garcia-Osta, Julen Oyarzábal
Impact of Scaffold Exploration on Novel Dual-Acting Histone Deacetylases and Phosphodiesterase 5 Inhibitors for the Treatment of Alzheimer's Disease. ACS chemical neuroscience 8 (3) (2016)

Julen Oyarzábal.css-eqlu8i{font-size:small;padding-left:4px;} (Julen Oyarzabal)

Publication Activity (10 Years)

Top Topics

Top Venues

Julen Oyarzábal (Julen Oyarzabal)